College of Pharmacy, Jiamusi University, Jiamusi, China.
Department of Emergency Surgery, The First Affiliated Hospital of Jiamusi University, Jiamusi, China.
Front Endocrinol (Lausanne). 2023 Mar 1;14:1149751. doi: 10.3389/fendo.2023.1149751. eCollection 2023.
Obesity, a chronic metabolic disease with a complex pathophysiology, is caused by several variables. High-fat diets lead to the disruption of the gut microbiota and impaired gut barrier function in obese people. The dysbiosis and its metabolites through the intestinal barrier lead to an imbalance in energy metabolism and inflammatory response, which eventually contributes to the development of chronic diseases such as diabetes, hypertension, and cardiovascular disease. Current medicines are therapeutic to obesity in the short term; however, they may bring significant physical and emotional problems to patients as major side effects. Therefore, it is urgent to explore new therapeutic methods that have definite efficacy, can be taken for a long time, and have mild adverse effects. Numerous studies have demonstrated that traditional Chinese medicine (TCM) can control the gut microbiota in a multi-targeted and comprehensive manner, thereby restoring flora homeostasis, repairing damaged intestinal mucosal barriers, and eventually curbing the development of obesity. The active ingredients and compounds of TCM can restore the normal physiological function of the intestinal mucosal barrier by regulating gut microbiota to regulate energy metabolism, inhibit fat accumulation, affect food appetite, and reduce intestinal mucosal inflammatory response, thereby effectively promoting weight loss and providing new strategies for obesity prevention and treatment. Although there are some studies on the regulation of gut microbiota by TCM to prevent and treat obesity, all of them have the disadvantage of being systematic and comprehensive. Therefore, this work comprehensively describes the molecular mechanism of obesity mediated by gut microbiota based on the research state of obesity, gut microbiota, and TCM. A comprehensive and systematic summary of TCM targeting the regulation of gut microbiota for the treatment of obesity should be conducted in order to provide new strategies and ideas for the treatment of obesity.
肥胖是一种由多种因素引起的慢性代谢性疾病,其发病机制十分复杂。高脂肪饮食会导致肥胖人群的肠道微生物群紊乱和肠道屏障功能受损。肠道微生物群失调及其代谢产物通过肠道屏障导致能量代谢和炎症反应失衡,最终导致糖尿病、高血压和心血管疾病等慢性疾病的发生。目前的药物虽然在短期内对肥胖症有治疗作用,但可能会给患者带来严重的身体和情绪问题,因为这些药物存在重大的副作用。因此,迫切需要探索新的治疗方法,这些方法不仅要有明确的疗效,而且能长期服用,副作用较小。大量研究表明,中药可以多靶点、全面地控制肠道微生物群,从而恢复菌群平衡,修复受损的肠道黏膜屏障,最终抑制肥胖的发展。中药的活性成分和化合物可以通过调节肠道微生物群来调节能量代谢,抑制脂肪堆积,影响食物食欲,减轻肠道黏膜炎症反应,从而恢复肠道黏膜屏障的正常生理功能,有效促进体重减轻,并为肥胖的预防和治疗提供新策略。虽然有一些关于中药通过调节肠道微生物群来预防和治疗肥胖的研究,但所有这些研究都有系统性和全面性不足的缺点。因此,本工作基于肥胖症、肠道微生物群和中药的研究现状,全面描述了肠道微生物群介导的肥胖的分子机制。应该对中药靶向调节肠道微生物群治疗肥胖症进行全面系统的总结,为肥胖症的治疗提供新的策略和思路。